Cargando…
Anemoside B4 ameliorates TNBS-induced colitis through S100A9/MAPK/NF-κB signaling pathway
BACKGROUND: Despite the increased morbidity of ulcerative colitis (UC) in the developing countries, available treatments remain unsatisfactory. Therefore, it is urgent to discover more effective therapeutic strategies. Pulsatilla chinensis was widely used for the treatment of inflamed intestinal dis...
Autores principales: | Zhang, Yong, Zha, Zhengxia, Shen, Wenhua, Li, Dan, Kang, Naixin, Chen, Zhong, Liu, Yanli, Xu, Guoqiang, Xu, Qiongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814617/ https://www.ncbi.nlm.nih.gov/pubmed/33461587 http://dx.doi.org/10.1186/s13020-020-00410-1 |
Ejemplares similares
-
Kalopanaxsaponin B Ameliorates TNBS-Induced Colitis in Mice
por: Jeong, Jun-ju, et al.
Publicado: (2012) -
Amelioration of Severe TNBS Induced Colitis by Novel AP-1 and NF-κB Inhibitors in Rats
por: El-Salhy, Magdy, et al.
Publicado: (2014) -
Resveratrol Pretreatment Ameliorates TNBS Colitis in Rats
por: Yildiz, Gulserap, et al.
Publicado: (2015) -
Anemoside B4 Protects against Acute Lung Injury by Attenuating Inflammation through Blocking NLRP3 Inflammasome Activation and TLR4 Dimerization
por: Yuan, Renyikun, et al.
Publicado: (2020) -
Esculentoside A could attenuate apoptosis and inflammation in TNBS-induced ulcerative colitis via inhibiting the nuclear translocation of NF-κB
por: Liu, Ying, et al.
Publicado: (2022)